IGG SUBCLASS & FUNCTION OF ANTIPOLYSACCHARIDE ANTIBODY
IGG亚类
基本信息
- 批准号:2067506
- 负责人:
- 金额:$ 22.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-01-01 至 1996-12-31
- 项目状态:已结题
- 来源:
- 关键词:Pseudomonas aeruginosa antibacterial antibody bacterial disease bacterial polysaccharides bactericidal immunity chimeric proteins complement pathway disease /disorder model fusion gene gene mutation gene rearrangement human genetic material tag human tissue humoral immunity immunodeficiency immunoglobulin G immunoglobulin genes laboratory mouse laboratory rat molecular cloning monoclonal antibody opsonin tissue /cell culture transfection
项目摘要
Polysaccharide (PS)-encapsulated bacteria are a major cause of infections
in humans. Anti-PS IgG antibodies (Ab) are critical to host defense
against infection with these bacteria. The function of anti-PS Ab
includes complement fixation and opsonization of bacteria for uptake and
killing by phagocytes. The mammalian IgG anti-PS Ab response, however
is restricted to only one or two subclasses (IgG3 in mice, IgG1 and IgG2
in man). Defining the relative function of anti-PS Ab of different IgG
subclasses is crucial to better understanding of immunity to PS-coated
bacteria as well as the pathogenesis of several human disease states such
as IgG subclass deficiency, and chronic pneumonia in Cystic Fibrosis
where inappropriate IgG subclass of anti-P. aeruginosa (PA) Ab may
contribute to inability to clear PA from the lung. The relative function
of anti-PS Ab of different IgG subclass remains unclear due to previous
studies primarily using polyclonal affinity purified Ab exposed to
chaotropic agents that alter Fc function, or to the use of monoclonal Ab
with different antigenic specificities. In this proposal, we will
precisely define the role of IgG subclass in anti-PS Ab effector
function. First, we will make murine monoclonal Ab (MAb) directed to O-
PS-side chain of PA LPS and to mucoid exopolysaccharide of PA. Next,
using sequential sublining, we will make switch variants of these MAb
that have identical variable regions but are of different IgG subclasses.
The variable region genes will be cloned and ligated to the gamma
constant region human genes to make human/murine chimeric transfectomas
producing Ab of all four human IgG subclasses that have identical
variable regions. The functional characteristics of the murine and
chimeric anti-PS Ab will be compared in terms of: 1) ability to fix
complement, 2) ability to opsonize PA for uptake by phagocytes, and 3)
protective efficacy in animal models of PA infection. Finally, to
determine the in vivo importance of the predominant anti-PS IgG subclass,
IgG3 deficient mice will be mae by targeting the murine gamma 3 gene for
mutation and homologous recombination in embryonic stem cells. These
mice will be evaluated for their ability to immunologically respond to
PS, PS-protein conjugates, and bacterial infection. These studies will
determine which anti-PS IgG subclass functions most efficiently against
PS-coated bacteria, better define the mechanism of functional differences
between IgG subclasses and explore the immunologic relevance of these
differences in vivo. This information will allow more rational
strategies of active and passive immunization against PS-coated bacteria
and improved treatment of IgG subclass deficiencies.
多糖(PS)包裹的细菌是感染的主要原因
在人类身上。 抗PS IgG抗体(Ab)对宿主防御至关重要
抵抗这些细菌的感染 抗PS抗体的功能
包括补体固定和细菌的调理作用以供吸收,
被吞噬细胞杀死。 然而,哺乳动物IgG抗PS Ab反应
仅限于一个或两个亚类(小鼠中的IgG 3,IgG 1和IgG 2
在人类中)。 不同IgG抗PS抗体的相关功能测定
亚类是至关重要的,以更好地了解免疫PS包被
细菌以及几种人类疾病状态的发病机制,
IgG亚类缺乏症和囊性纤维化中的慢性肺炎
当抗铜绿假单胞菌(PA)Ab的不适当IgG亚类可能
导致不能从肺中清除PA。 相对函数
不同IgG亚类的抗PS抗体的数量仍不清楚,
研究主要使用多克隆亲和纯化的Ab暴露于
改变Fc功能的离液剂,或使用单克隆抗体
具有不同的抗原特异性。 在本提案中,我们将
精确定义IgG亚类在抗PS Ab效应子中的作用
功能 首先,我们将制备针对O-
PA LPS的PS-侧链和PA的粘液样胞外多糖。 接下来,
使用连续的亚线,我们将使这些单克隆抗体的开关变体
具有相同的可变区但属于不同的IgG亚类。
可变区基因将被克隆并连接到γ
恒定区人基因以制备人/鼠嵌合转染瘤
产生所有四种人IgG亚类的Ab,其具有相同的
可变区 小鼠的功能特征和
嵌合抗PS Ab将在以下方面进行比较:1)固定
补体,2)调理PA以供吞噬细胞摄取的能力,以及3)
在PA感染动物模型中的保护功效。 最后为
确定主要抗PS IgG亚类的体内重要性,
IgG 3缺陷型小鼠将通过靶向鼠γ 3基因来制备,
胚胎干细胞中的突变和同源重组。 这些
将评价小鼠免疫应答的能力,
PS、PS-蛋白结合物和细菌感染。 这些研究将
确定哪种抗PS IgG亚类对
PS包被细菌,更好地定义功能差异的机制
IgG亚类之间,并探讨这些免疫相关性
体内差异 这些信息将使我们更理性
PS包被细菌的主动和被动免疫策略
和改善IgG亚类缺陷的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN R SCHREIBER其他文献
JOHN R SCHREIBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN R SCHREIBER', 18)}}的其他基金
HUMAN T CELL RESPONSE TO PNEUMOCOCCAL CONJUGATE VACCINES
人类 T 细胞对肺炎球菌结合疫苗的反应
- 批准号:
6511181 - 财政年份:2000
- 资助金额:
$ 22.22万 - 项目类别:
HUMAN T CELL RESPONSE TO PNEUMOCOCCAL CONJUGATE VACCINES
人类 T 细胞对肺炎球菌结合疫苗的反应
- 批准号:
6374389 - 财政年份:2000
- 资助金额:
$ 22.22万 - 项目类别:
HUMAN T CELL RESPONSE TO PNEUMOCOCCAL CONJUGATE VACCINES
人类 T 细胞对肺炎球菌结合疫苗的反应
- 批准号:
6632203 - 财政年份:2000
- 资助金额:
$ 22.22万 - 项目类别:
HUMAN T CELL RESPONSE TO PNEUMOCOCCAL CONJUGATE VACCINES
人类 T 细胞对肺炎球菌结合疫苗的反应
- 批准号:
6756507 - 财政年份:2000
- 资助金额:
$ 22.22万 - 项目类别:
HUMAN T CELL RESPONSE TO PNEUMOCOCCAL CONJUGATE VACCINES
人类 T 细胞对肺炎球菌结合疫苗的反应
- 批准号:
6195663 - 财政年份:2000
- 资助金额:
$ 22.22万 - 项目类别:
Teaching Biology Through Immunology Fellowships
通过免疫学奖学金教授生物学
- 批准号:
6666522 - 财政年份:1998
- 资助金额:
$ 22.22万 - 项目类别:
TEACHING BIOLOGY THROUGH IMMUNOLOGY FELLOWSHIPS
通过免疫学奖学金教授生物学
- 批准号:
6532756 - 财政年份:1998
- 资助金额:
$ 22.22万 - 项目类别:
TEACHING BIOLOGY THROUGH IMMUNOLOGY FELLOWSHIPS
通过免疫学奖学金教授生物学
- 批准号:
6373965 - 财政年份:1998
- 资助金额:
$ 22.22万 - 项目类别: